HAVN Life Sciences Inc (CSE:HAVN)
HENDERSON, BC, UNITED STATES, October 14, 2022 /EINPresswire.com/ — HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) declares the departure of Mr. Gary Leong and Mr. Gordon Clissold as administrators on the Board of the Company, efficient instantly. Mr. Clissold can be departing as CFO of the Company. With Mr. Clissold’s departure, Mr. Tim Moore, Chairman, and CEO assumes the position of Interim CFO.
Joining the Board are Mr. Alexzander Samuelsson and Dr. Ivan Casselman.
The Company expresses its appreciation for Mr. Clissold and Mr. Leong’s service and needs them effectively in future endeavors.
On Behalf of The Board of Directors
Tim Moore
Chief Executive Officer and Chairman of the Board
About HAVN Life Sciences Inc.
HAVN Life Sciences is a biotechnology firm pursuing standardized extraction of psychedelic compounds for the creation of APIs, the event of pure well being merchandise, and modern therapies to assist mind well being and improve the capabilities of the thoughts. Through its analysis division, HAVN Labs, the corporate has developed an end-to-end provide chain of GMP naturally derived psychedelic compounds for analysis that can outline the way forward for trendy drugs. With its new line of pure well being merchandise, HAVN Life affords a full vary of high-quality mushroom and plant extracts that assist increase immune operate, scale back irritation and assist a wholesome life-style.
Contact:
Investor Relations: [email protected]
Media: [email protected]
The CSE has not reviewed, accepted or disapproved the content material of this press launch.
Tim Moore
Havn Life Sciences Inc.
+1 6479666536
e-mail us right here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other
